Application 761053

Application Products#

Product, Drug, Ingredient table
Product	Drug	Ingredient	Form	Strength	Reference drug	Reference standard
001	OCREVUS	OCRELIZUMAB	INJECTABLE;INJECTION	30MG/1ML	No	No

NDC, Name, Nonproprietary name table
NDC	Name	Nonproprietary name	Labeler	Marketing category	Status
50242-150	OCREVUS	ocrelizumab	Genentech, Inc.	BLA	Current
50242-150	OCREVUS	ocrelizumab	Genentech, Inc.	BLA	Current
50242-150	OCREVUS	ocrelizumab	Genentech, Inc.	BLA	Current
50242-150	OCREVUS	ocrelizumab	Genentech, Inc.	BLA	Current
50242-150	OCREVUS	ocrelizumab	Genentech, Inc.	BLA	Current
50242-150	OCREVUS	ocrelizumab	Genentech, Inc.	BLA	Current
50242-150	OCREVUS	ocrelizumab	Genentech, Inc.	BLA	Current
50242-150	OCREVUS	ocrelizumab	Genentech, Inc.	BLA	Current
50242-150	OCREVUS	ocrelizumab	Genentech, Inc.	BLA	Current
50242-150	OCREVUS	ocrelizumab	Genentech, Inc.	BLA	Current
50242-150	OCREVUS	ocrelizumab	Genentech, Inc.	BLA	Current